Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group (Q36905131)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 1995

Language	Label	Description	Also known as
English	Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group	scientific article published on October 1995

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group (English)

1 reference

Europe PubMed Central

17 August 2017

0 references

author name string

Bräutigam M

1

1 reference

Europe PubMed Central

17 August 2017

Nolting S

2

1 reference

Europe PubMed Central

17 August 2017

Schopf RE

3

1 reference

Europe PubMed Central

17 August 2017

Weidinger G

4

1 reference

Europe PubMed Central

17 August 2017

language of work or name

0 references

publication date

1 October 1995

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

311

1 reference

Europe PubMed Central

17 August 2017

7010

1 reference

Europe PubMed Central

17 August 2017

919-922

1 reference

Europe PubMed Central

17 August 2017

GRISEOFULVIN: BIOLOGY AND CLINICAL USEFULNESS. A REVIEW.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

29 September 2017

Taste disorders and terbinafine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

29 September 2017

Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

29 September 2017

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

29 September 2017

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

29 September 2017

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

29 September 2017

Treatment of onychomycosis with terbinafine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

27 June 2018

A randomized treatment duration-finding study of terbinafine in onychomycosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

27 June 2018

Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

27 June 2018

Open randomized comparison of itraconazole versus terbinafine in onychomycosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

4 September 2018

Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2550920

4 September 2018

A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days

1 reference

https://pubmed.ncbi.nlm.nih.gov/7580551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.311.7010.919

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36905131&oldid=2088496285"